r
e
v
e
w
potent
adapt
immun
system
fundament
reliant
upon
gener
divers
repertoir
blymphocyt
antigen
receptor
bcr
membranebound
form
antibodi
express
surfac
b
cell
bcr
assembl
somat
recombin
larg
number
immunoglobulin
gene
segment
fig
repertoir
bcr
express
given
individu
continu
shape
exposur
exogen
antigen
endogen
host
factor
exist
mechan
bcr
diversif
yield
astronom
number
possibl
bcr
theori
human
number
exce
total
number
b
lymphocyt
human
bodi
ref
labor
cost
consider
complet
impract
analyz
divers
bcr
repertoir
use
tradit
sanger
sequenc
howev
igseq
term
coin
andrew
fire
stanford
univers
allow
us
determin
antibodi
gene
repertoir
unpreced
depth
inform
gain
igseq
prove
invalu
understand
antibodi
respons
health
diseas
diagnost
purpos
addit
igseq
combin
techniqu
includ
express
isol
antigenspecif
antibodi
sequenc
multipl
rna
singl
cell
proteom
analys
antibodi
blood
secret
help
elucid
properti
antibodi
mediat
protect
infecti
diseas
altern
mediat
autoimmun
respons
review
describ
experiment
approach
technic
challeng
relat
highthroughput
antibodi
gene
sequenc
well
way
igseq
might
appli
advanc
understand
immunolog
address
unmet
clinic
need
relat
infecti
diseas
immun
dysregul
cancer
gener
antibodi
repertoir
antibodi
produc
development
order
seri
somat
gene
rearrang
event
occur
exclus
develop
b
cell
continu
throughout
life
organ
antibodi
consist
heavi
light
chain
link
disulfid
bond
intact
antibodi
contain
variabl
constant
domain
fig
antigen
bind
occur
variabl
domain
gener
recombin
finit
set
tandemli
arrang
variabl
v
divers
join
j
germlin
gene
segment
fig
process
call
vdj
recombin
often
result
addit
delet
nucleotid
junction
ligat
gene
segment
fig
specif
dna
exonucleas
trim
end
gene
segment
dna
polymeras
transferas
randomli
insert
templat
palindrom
nontempl
nucleotid
respect
bcell
develop
immunoglobulin
heavi
igh
chain
gene
recombin
typic
occur
immunoglobulin
light
igl
chain
gene
recombin
igh
igl
gene
product
rearrang
fulli
assembl
antibodi
heterodim
express
surfac
b
cell
b
cell
bear
product
rearrang
antibodi
process
allel
exclus
locu
exclus
case
igl
ensur
b
cell
express
singl
antibodi
passag
sever
development
checkpoint
newli
gener
matur
igm
igd
b
cell
form
naiv
b
cell
therefor
naiv
antibodi
repertoir
divers
naiv
effort
determin
antibodi
repertoir
encod
b
cell
blood
lymphoid
organ
use
highthroughput
dna
sequenc
technolog
advanc
extrem
rapid
pace
transform
understand
humor
immun
respons
inform
gain
highthroughput
dna
sequenc
immunoglobulin
gene
igseq
appli
detect
bcell
malign
high
sensit
discov
antibodi
specif
antigen
interest
guid
vaccin
develop
understand
autoimmun
rapid
progress
develop
experiment
protocol
informat
analysi
tool
help
reduc
sequenc
artifact
achiev
precis
quantif
clonal
divers
extract
pertin
biolog
inform
said
broader
applic
igseq
especi
clinic
set
requir
develop
standard
experiment
design
framework
enabl
share
metaanalysi
sequenc
data
gener
differ
laboratori
antibodi
repertoir
concentr
site
igh
vdj
gene
segment
ligat
also
known
igh
complementaritydetermin
region
fig
combinatori
nontempl
natur
mechan
gener
divers
compon
term
length
sequenc
antibodi
hchain
repertoir
princip
determin
antibodi
specif
nonetheless
instanc
antigen
specif
dictat
sole
predominantli
l
chain
b
cell
encount
antigen
environ
provid
requisit
costimulatori
signal
tcell
help
bcr
stimul
induc
bcell
prolifer
process
known
bcell
clonal
expans
occur
primarili
highli
organ
area
secondari
lymphoid
organ
eg
spleen
lymph
node
peyer
patch
refer
germin
center
fig
clonal
expans
follow
somat
hypermut
variabl
domain
antibodi
mediat
activationinduc
cytidin
deaminas
b
cell
express
bcr
bear
somat
mutat
increas
affin
antigen
outcompet
b
cell
access
antigen
result
b
cell
bear
highestaffin
antibodi
undergo
preferenti
expans
surviv
process
refer
affin
matur
somat
hypermut
also
result
sequenc
diversif
hypervari
region
framework
region
propos
constitut
fourth
hypervari
region
antibodi
h
chain
activationinduc
cytidin
deaminas
also
mediat
classswitch
recombin
gener
antibodi
bear
differ
constant
region
b
cell
express
somat
mutat
highantigenaffin
bcr
differenti
longliv
memori
b
cell
capabl
mediat
rapid
recal
respons
antigen
termin
differenti
plasma
cell
latter
downregul
bcr
express
establish
resid
bone
marrow
gut
lamina
propia
smaller
degre
secondari
lymphoid
tissu
secret
protect
antibodi
extrem
high
rate
estim
antibodi
molecul
per
second
antibodi
product
longliv
plasma
cell
bone
marrow
postul
proceed
long
time
possibl
throughout
entir
lifetim
organ
divers
primari
antibodi
repertoir
exogen
antigen
exposur
stem
allel
divers
immunoglobulin
gene
segment
combinatori
divers
introduc
somat
recombin
junction
divers
caus
imprecis
recombin
process
pair
igh
igl
polypeptid
chain
receptor
edit
wherein
exist
vgene
segment
replac
anoth
fig
addit
v
h
replac
process
result
presenc
cryptic
recombin
signal
sequenc
might
influenc
much
human
primari
bcell
antibodi
repertoir
diversif
postantigenstimul
secondari
antibodi
repertoir
stem
somat
hypermut
classswitch
recombin
organ
age
also
influenc
antibodi
repertoir
earli
ontogeni
mammalian
adult
bcell
repertoir
gener
predict
development
program
fashion
wherea
advanc
age
humor
immun
respons
deterior
phenomenon
refer
immunosenesc
thought
attribut
part
progress
restrict
antibodi
repertoir
exampl
among
elderli
increas
preval
autoantibodi
serolog
level
increas
amount
either
singl
small
number
serum
immunoglobulin
produc
high
level
benign
outgrowth
one
plasma
cell
clone
lowthroughput
analysi
antibodi
repertoir
sanger
sequenc
enabl
determin
igh
igl
vdj
recombin
hereaft
simpli
refer
v
gene
typic
hundr
b
cell
per
experi
subsequ
studi
began
clone
immunoglobulin
gene
singl
b
cell
follow
limit
dilut
express
function
character
clone
antibodi
protein
thu
enabl
interrog
antibodi
specif
advanc
prove
invalu
isol
antibodi
relev
diseas
especi
isol
pathogenneutr
antibodi
bcell
immort
subsequ
sequenc
v
gene
immort
b
clone
provid
altern
rout
express
small
number
antibodi
abil
interrog
antibodi
encod
small
number
b
cell
yield
numer
import
immunolog
insight
exampl
wardemann
et
al
first
use
singlecel
clone
antibodi
express
demonstr
fraction
newli
gener
b
cell
human
bone
marrow
express
selfand
polyreact
antibodi
develop
regul
two
independ
selftoler
checkpoint
subsequ
studi
laboratori
other
elucid
mechan
featur
antibodi
associ
autoimmun
diseas
immunodefici
syndrom
bcell
clone
techniqu
also
enabl
isol
antibodi
abl
neutral
numer
clinic
import
pathogen
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
influenza
among
mani
other
understand
mechan
lead
elicit
neutral
antibodi
turn
help
research
design
effect
vaccin
nonetheless
one
key
limit
lowthroughput
bcell
clone
studi
provid
glimps
miniscul
slice
full
antibodi
repertoir
highthroughput
sequenc
antibodi
repertoir
compar
sanger
sequenc
igseq
provid
much
broader
pictur
antibodi
repertoir
fig
although
conceptu
simpl
proper
applic
igseq
demand
thought
consider
experiment
design
detail
understand
sourc
dna
sequenc
quantif
error
abil
delin
v
h
gene
pair
v
l
gene
singl
b
cell
use
appropri
data
mine
visual
tool
make
biolog
sens
larg
amount
inform
gener
experi
human
antibodi
sequenc
studi
use
b
cell
peripher
blood
blood
one
readili
access
sourc
b
cell
human
tonsil
one
howev
estim
b
cell
human
bodi
present
peripher
blood
compar
almost
lymph
node
spleen
mucos
surfac
red
bone
marrow
medulla
ossium
rubra
thu
antibodi
repertoir
peripher
b
cell
provid
narrow
view
humor
respons
antigen
challeng
second
import
consid
whether
use
genom
dna
gdna
mrna
immunoglobulin
sequenc
analys
fig
whether
one
use
gdna
mrna
depend
question
ask
sequenc
gdna
facilit
estim
clonal
given
ig
sequenc
word
number
b
cell
express
antibodi
number
sequenc
read
gener
proport
number
npg
r
e
v
e
w
gdna
templat
molecul
assum
primer
bias
discuss
hand
use
mrna
templat
provid
estim
rel
express
level
variou
immunoglobulin
sequenc
repertoir
howev
immunoglobulin
transcript
vari
dramat
naiv
b
cell
plasma
cell
fig
use
unsort
bulk
b
cell
peripher
blood
sourc
mrna
make
challeng
deduc
cellular
clonal
frequenc
unsort
peripher
blood
mononuclear
cell
use
sourc
mrna
degre
somat
hypermut
sequenc
data
set
may
employ
ipso
facto
distinguish
vgene
transcript
deriv
antigenexperienc
versu
naiv
b
cell
altern
cellsurfac
marker
use
sort
bcell
subset
interest
mrna
isol
complic
comparison
repertoir
differ
studi
recent
work
unveil
unexpectedli
high
degre
polymorph
human
igh
locu
understand
degre
genet
variat
critic
assign
vdj
segment
usag
estim
somat
hypermut
compar
antibodi
respons
among
individu
anoth
experiment
design
consider
relat
larg
number
b
cell
human
b
cell
blood
alon
minim
sampl
depth
need
cover
antibodi
repertoir
extent
suffici
answer
particular
biolog
question
need
consid
clearli
sequenc
depth
must
greater
number
b
cell
sampl
mean
enumer
b
cell
fluorescenceactiv
cell
sort
essenti
requir
sequenc
depth
also
depend
approach
use
minim
pcr
basecal
error
see
distinguish
error
true
biolog
variat
two
sourc
sequenc
error
aris
sampl
prepar
revers
transcript
pcr
inher
dna
sequenc
platform
rel
clonal
frequenc
estim
gdna
prepar
sequenc
librari
multipl
aliquot
sampl
technic
replic
approach
aliquot
use
gener
barcod
librari
result
librari
differ
aliquot
sequenc
barcod
prevent
artifact
due
contamin
one
librari
dna
differ
aliquot
npg
r
e
v
e
w
respect
clonal
b
cell
present
start
aliquot
method
reveal
clonal
expans
howev
use
gdna
templat
without
complic
first
amplif
vdj
segment
gdna
necessit
use
primer
set
anneal
individu
germlin
vgene
segment
fig
anoth
drawback
gdnaderiv
antibodi
gene
librari
contain
product
nonproduct
vdj
rearrang
latter
also
present
cdna
librari
much
lower
frequenc
due
decay
nonsens
rna
lastli
lower
concentr
templat
gdna
necessit
greater
number
pcr
cycl
increas
error
frequenc
confound
quantif
use
mrna
start
materi
enabl
amplif
revers
transcript
rapid
amplif
cdna
end
primer
anneal
constant
region
igh
igl
thu
circumv
need
complex
vgenespecif
primer
set
fig
start
mrna
error
introduc
revers
transcriptas
minim
use
commerci
highfidel
retrovir
revers
transcriptas
thermost
group
ii
intron
revers
transcriptas
regardless
whether
gdna
cdna
use
templat
pcr
introduc
amplif
artifact
owe
differenti
amplif
dna
templat
other
even
base
misincorpor
templat
switch
latter
result
chimera
join
fragment
encod
two
templat
dna
nucleotid
misincorpor
pcr
gener
distinguish
type
basecal
error
introduc
sequenc
latter
gener
occur
higher
frequenc
henc
greater
concern
chimera
result
templat
switch
gener
sequenc
either
assign
germlin
vgene
segment
standard
vdj
identif
algorithm
interpret
artifactu
high
rate
somat
hypermut
presenc
chimera
make
discern
true
v
h
gene
replac
event
particularli
challeng
howev
fact
gene
replac
definit
involv
recombin
upstream
v
h
gene
segment
chromosom
downstream
v
h
gene
segment
delet
primari
recombin
event
use
assist
identif
true
v
h
replac
event
quantif
bias
introduc
pcr
may
minim
amplifi
sequenc
sampl
two
differ
primer
set
follow
informat
comparison
similar
respect
dataset
anoth
possibl
solut
use
emuls
pcr
sequest
individu
dna
molecul
amplif
sever
complic
underli
dna
sequenc
error
recent
review
focu
issu
pertin
igseq
recent
technolog
advanc
aim
increas
sequenc
accuraci
antibodi
repertoir
sequenc
error
relat
particular
dna
sequenc
technolog
use
experi
encompass
incorrect
base
assign
insert
delet
collect
known
indel
ambigu
base
call
pyrosequencingbas
technolog
roch
iontorr
domin
indel
wherea
dyelabel
revers
termin
technolog
illumina
hiseq
miseq
domin
substitut
error
indel
gener
pyrosequenc
method
aris
frequenc
around
comput
account
variou
degre
success
accord
recent
analysi
frequenc
base
substitut
vari
depend
platform
overal
illumina
platform
suitabl
igseq
applic
combin
rel
low
basecal
error
rate
rel
low
cost
note
import
sequenc
error
depend
object
antibodi
repertoir
sequenc
experi
exampl
object
gener
length
distribut
statist
vj
segment
use
statist
sequenc
error
less
problem
meaning
inform
obtain
use
cluster
algorithm
group
togeth
highli
homolog
sequenc
minim
effect
sequenc
error
applic
sequenc
accuraci
critic
number
recent
develop
approach
help
reduc
sequenc
error
exampl
tenfold
higher
sequenc
accuraci
attain
use
circular
vgene
dna
sequenc
multipl
time
use
pacbio
platform
howev
accuraci
come
higher
cost
much
lower
throughput
variou
dna
barcod
techniqu
wherebi
nucleotid
barcod
append
dna
templat
molecul
pcr
amplif
also
improv
sequenc
accuraci
barcod
enabl
accur
quantif
dna
templat
molecul
origin
librari
count
barcod
instead
sequenc
read
error
correct
gener
consensu
read
barcod
recent
applic
barcod
igseq
quak
laboratori
achiev
ident
vgene
repertoir
sequenc
present
read
two
technic
replic
anoth
method
reli
barcod
sequenc
strand
achiev
high
accuraci
error
rate
although
expens
throughput
identifi
endogen
v
h
v
l
pair
discuss
recent
nativ
v
h
v
l
pair
could
identifi
singlecel
clone
limit
dilut
sanger
sequenc
individu
v
h
v
l
gene
process
inher
low
throughput
expens
due
high
reagent
usag
yield
limit
set
antibodi
sequenc
modest
increas
singlecel
clone
throughput
b
cell
achiev
use
overlap
extens
pcr
produc
singl
v
h
v
l
amplicon
oppos
separ
v
h
v
l
cdna
sanger
sequenc
studi
quak
laboratori
weinstein
et
al
sort
mous
b
cell
microwel
follow
quantit
rtpcr
microfluid
chip
use
primer
specif
gene
interest
also
contain
sequenc
adapt
thu
enabl
correl
express
multipl
gene
degre
somat
hypermut
antibodi
heavi
light
chain
gene
addit
approach
sequenc
endogen
v
h
v
l
pair
recent
develop
wardemann
georgiou
laboratori
buss
et
al
use
twodimension
barcod
primer
matrix
combin
singlecel
v
h
v
l
gene
amplif
highthroughput
sequenc
increas
throughput
total
individu
b
cell
fig
importantli
approach
also
enabl
facil
clone
igh
sequenc
express
vector
antibodi
character
dekoski
et
al
develop
v
h
v
l
pair
technolog
reli
sequest
singl
b
cell
subnanolit
volum
well
lyse
cell
captur
rna
polydt
bead
gener
amplicon
encod
link
v
h
v
l
segment
emuls
overlap
extens
pcr
fig
yield
uniqu
v
h
v
l
pair
activ
memori
b
cell
oneday
experi
valid
pair
accuraci
report
method
adapt
detect
coexpress
v
gene
transcript
factor
interest
eg
antibodysecret
cell
bj
dekoski
person
commun
much
higherthroughput
method
b
cell
per
experi
develop
laboratori
reli
cell
encapsul
within
control
microdroplet
diamet
emuls
import
consider
revers
transcriptas
inhibit
npg
r
e
v
e
w
droplet
nl
volum
unpublish
data
altern
singl
cell
encapsul
waterinoil
emuls
togeth
uniqu
barcod
bead
use
microfluid
devic
revers
transcriptas
pcr
everi
rna
molecul
origin
singl
cell
effect
load
onto
uniqu
barcod
bead
pcr
product
sequenc
illumina
platform
correctli
pair
v
h
v
l
sequenc
identifi
virtu
share
barcod
fig
given
rapid
pace
technolog
advanc
may
expect
near
futur
antibodi
repertoir
analys
report
nativ
pair
v
h
v
l
gene
bioinformat
analysi
antibodi
sequenc
sever
establish
method
vdj
assign
identif
avail
eg
imgtvquest
igblast
ihmmunealign
faster
precis
algorithm
continu
develop
estim
size
antibodi
repertoir
accomplish
rarefact
analysi
maximum
entropi
poisson
lognorm
distribut
model
also
mani
approach
cluster
v
gene
like
origin
expans
somat
hypermut
singl
b
cell
encod
unmut
antibodi
precursor
howev
cluster
becom
particularli
problemat
sequenc
depth
repertoir
divers
increas
likewis
infer
v
h
evolut
ie
somat
mutat
v
gene
aris
precursor
sequenc
initi
present
naiv
primari
repertoir
major
challeng
final
note
research
work
area
gener
use
custommad
bioinformat
pipelin
lack
standard
share
comput
resourc
make
extrem
difficult
carri
metaanalys
publish
data
gener
differ
laboratori
key
issu
need
address
field
matur
interchang
data
format
deposit
central
databas
valid
opensourc
algorithm
data
analysi
standard
igseq
experiment
descript
analog
minimum
inform
microarray
experi
critic
need
igseq
find
wide
rang
basic
appli
immunolog
applic
antibodi
discoveri
screen
larg
combinatori
librari
ribosom
phage
bacteri
yeast
display
wide
employ
isol
antibodi
capabl
bind
virtual
ligand
combinatori
librari
typic
gener
random
pair
larg
typic
ensembl
v
h
v
l
gene
isol
mammal
naiv
immun
librari
depend
whether
anim
immun
altern
one
use
synthet
librari
singl
small
set
v
h
v
l
gene
diversifi
mutagenesi
cdr
screen
involv
sequenti
round
bind
antigen
process
progress
restrict
divers
librari
antibodi
clone
requisit
affin
specif
other
use
highthroughput
sequenc
mean
evalu
initi
divers
antibodi
encod
librari
determin
divers
declin
binder
antigen
progress
enrich
librari
screen
antibodi
divers
reduc
antigenbind
clone
enrich
background
unrel
antibodi
start
librari
howev
express
antibodi
high
affin
often
advers
affect
growth
cell
encod
nota
bene
antibodi
poor
affin
equal
like
advers
effect
cell
growth
obvious
clone
interest
librari
screen
result
respect
antibodi
gene
enrich
earli
round
screen
antigen
bind
progress
deplet
outcompet
faster
grow
cell
express
lower
qualiti
antibodi
highthroughput
sequenc
librari
follow
one
two
round
select
antigen
bind
therefor
use
rescu
clone
encod
highaffin
antibodi
could
discov
otherwis
three
differ
approach
exploit
antibodi
repertoir
sequenc
analysi
antibodi
isol
directli
anim
human
without
librari
screen
develop
first
work
georgiou
laboratori
reddi
et
al
observ
mice
antibodi
repertoir
encod
antibodysecret
b
cell
bone
marrow
bone
marrow
plasma
cell
becom
highli
polar
seven
day
secondari
immun
antigen
abund
v
h
v
l
gene
repres
vgene
sequenc
discov
antigenspecif
antibodi
reddi
et
al
pair
v
h
v
l
gene
base
rel
rank
frequenc
respect
repertoir
thu
obtain
antibodi
nanomolar
affin
antigen
subsequ
saggi
et
al
show
v
h
gene
present
high
frequenc
splenic
vgene
repertoir
immun
mice
encod
antibodi
capabl
bind
immun
antigen
howev
type
bone
marrow
spleen
sampl
use
mous
analys
rare
avail
human
differ
approach
pioneer
shapiro
kwong
cowork
build
observ
coevolut
heavi
light
chain
broadli
neutral
antibodi
reflect
match
topolog
v
h
v
l
phylogenet
tree
glean
igseq
v
h
v
l
gene
within
match
branch
respect
phylogenet
tree
display
similar
pattern
mutat
accumul
pair
yield
novel
broadli
neutral
antibodi
method
particularli
use
identif
antibodi
high
somat
hypermut
level
elicit
persist
infect
deep
phylogenet
tree
construct
igseq
also
enabl
proteom
identif
antibodi
biolog
fluid
even
though
main
effector
function
b
cell
secret
antibodi
blood
mucos
respiratori
epithelia
composit
antibodi
repertoir
bodili
fluid
remain
elus
other
realiz
shotgun
liquid
chromatographytandem
mass
spectrometri
lcmsm
proteom
identif
antibodi
compris
humor
respons
requir
match
person
antibodi
sequenc
databas
obtain
igseq
interpret
msm
spectra
fig
manner
polakiewicz
cowork
identifi
highaffin
antigenspecif
antibodi
immun
anim
human
vaccin
hepat
b
cytomegalovirusinfect
volunt
recent
studi
determin
monoclon
antibodi
repertoir
compris
serum
polyclon
respons
rabbit
human
follow
vaccin
unpublish
data
ref
advent
antibodi
discoveri
proteom
mine
serum
antibodi
respons
turn
open
way
isol
biolog
relev
antibodi
convalesc
patient
find
serum
antibodi
respons
resolut
diseas
state
patient
like
great
relev
drug
discoveri
antibodi
alreadi
establish
therapeut
valu
understand
immun
repertoir
develop
use
igseq
map
global
antibodi
repertoir
first
accomplish
quak
cowork
zebrafish
exhibit
basic
featur
adapt
immun
fewer
possibl
vdj
combin
npg
r
e
v
e
w
mice
human
igseq
subsequ
use
analyz
repertoir
varieti
speci
includ
mice
chicken
cattl
importantli
howev
igseq
provid
unpreced
insight
mechan
respons
shape
human
naiv
bcr
repertoir
note
igseq
analysi
v
h
repertoir
reveal
high
degre
allel
divers
human
immunoglobulin
locu
analysi
laboratori
other
germlin
v
h
segment
usag
frequenc
recombin
particular
vd
dj
segment
naiv
bcr
repertoir
reveal
mark
skew
turn
shape
repertoir
matur
antigenexperienc
b
cell
singl
dsegment
read
frame
overwhelmingli
prefer
vdj
recombin
invers
segment
extrem
rare
region
exhibit
univers
categor
constraint
respect
amino
acid
composit
averag
hydrophob
charg
distribut
length
antibodi
long
charg
great
clinic
interest
although
like
autoreact
often
enabl
bind
occlud
site
pathogen
mediat
pathogen
neutral
human
repertoir
long
aris
dd
join
occur
frequenc
naiv
repertoir
reduc
antigenexperienc
b
cell
extens
nucleotid
addit
combin
preferenti
usag
longer
segment
longer
segment
germlin
conserv
hydrophob
result
select
neutral
hydropath
extrem
charg
hydrophob
antibodybind
site
common
theme
across
vertebr
evolut
collect
find
indic
loop
human
explor
vast
sequenc
space
within
boundari
recent
studi
suggest
determin
vdj
recombin
frequenc
primari
antibodi
repertoir
vdj
segment
usag
antibodi
repertoir
homozygot
twin
indistinguish
suggest
determin
genet
factor
nonetheless
import
note
diversif
result
highli
privat
repertoir
show
littl
overlap
among
individu
human
naiv
antibodi
repertoir
develop
immunocompromis
mice
engraft
human
hematopoiet
stem
cell
show
vj
usag
pattern
even
strikingli
checkpoint
deplet
antibodi
display
autoreact
signatur
similar
human
import
insight
also
glean
sequenc
antibodi
repertoir
encod
b
cell
differ
anatom
site
one
particularli
noteworthi
studi
analyz
murin
intestin
iga
repertoir
anoth
studi
mous
mucos
bcell
repertoir
intestin
lamina
propria
rais
intrigu
possibl
contrari
longstand
dogma
bone
marrow
might
exclus
site
adult
bcell
develop
b
cell
gut
express
recombinas
display
preb
immatur
b
phenotyp
importantli
encod
distinct
v
l
repertoir
featur
consist
bcell
develop
select
situ
lamina
propria
igg
v
h
repertoir
cerebrospin
fluid
also
examin
found
differ
somat
hypermut
compar
peripher
blood
suggest
bcell
matur
might
occur
independ
central
nervou
system
peripheri
sever
studi
attempt
estim
total
divers
human
antibodi
repertoir
igseq
peripher
b
cell
task
challeng
owe
larg
size
antibodi
repertoir
variabl
sampl
depth
transcript
differ
among
bcell
subset
sequenc
error
last
least
fact
peripher
blood
contain
b
cell
overwhelm
major
publish
studi
well
unpublish
data
consist
notion
one
hand
v
h
gene
repertoir
highli
privat
uniqu
individu
although
small
number
appear
share
word
stereotyp
public
among
differ
individu
howev
sizabl
fraction
share
sequenc
found
light
chain
due
lower
divers
v
l
gene
repertoir
intrigu
share
igl
chain
gene
also
tend
abundantli
express
igseq
also
provid
insight
adapt
immun
respons
elicit
pathogen
challeng
vaccin
pathogen
challeng
affect
bcr
repertoir
respond
b
well
naiv
repertoir
mani
pathogen
produc
superantigen
protein
bind
certain
antibodi
v
domain
result
bcr
crosslink
subsequ
bcell
delet
predict
superantigen
exposur
result
skew
naiv
antibodi
repertoir
surprisingli
howev
deplet
v
gene
bound
superantigen
observ
naiv
repertoir
transgen
mice
constitut
express
superantigen
interestingli
skew
naiv
bcell
antibodi
repertoir
also
report
patient
chronic
evolv
hepat
c
infect
chang
overal
antibodi
repertoir
also
evid
follow
vaccin
infect
notabl
boyd
fire
cowork
observ
converg
antibodi
signatur
stereotyp
sequenc
patient
experienc
acut
dengu
infect
observ
rais
possibl
igseq
aim
detect
stereotyp
respons
may
use
diagnost
tool
predict
infecti
diseas
sever
anoth
excit
potenti
applic
igseq
identif
v
gene
clonal
relat
encod
protect
antibodi
isol
individu
one
infer
antibodi
lineag
led
evolut
protect
antibodi
start
unmut
common
ancestor
igh
germlin
sequenc
approach
particularli
relev
understand
evolut
broadli
neutral
antibodi
bnab
infect
rapidli
evolv
viral
pathogen
influenza
ref
figur
deconvolut
serum
antibodi
repertoir
b
cell
peripher
blood
tissu
sort
subject
highthroughput
immunoglobulin
vgene
sequenc
result
gener
person
antibodi
sequenc
databas
antigenspecif
antibodi
serum
isol
affin
chromatographi
digest
peptid
subject
lcmsm
analysi
msm
data
interpret
use
antibodi
sequenc
databas
therebi
allow
identif
peptid
gene
encod
repertoir
antigenspecif
antibodi
serum
ig
immunoglobulin
npg
r
e
v
e
w
adapt
immun
respons
exert
select
pressur
viru
emerg
viral
escap
mutat
trace
evolutionari
path
lead
gener
bnab
also
critic
design
immunogen
vaccin
schedul
elicit
immun
respons
first
activ
naiv
germlin
antibodyexpress
b
cell
steer
b
clonal
select
toward
affin
matur
pathway
lead
product
bnab
multidonor
analysi
bnab
confirm
elicit
antibodi
singl
ancestor
b
cell
inde
occur
multipl
individu
igseq
also
use
evalu
innat
immun
respons
elicit
adjuv
tolllik
receptor
agonist
affect
divers
antibodi
respons
possibl
antibodi
function
igseq
might
also
appli
answer
longstand
question
peopl
certain
age
group
usual
elderli
exhibit
higher
suscept
infecti
diseas
andor
less
wellprotect
vaccin
exampl
analyz
antibodi
lineag
structur
isotyp
mutat
load
v
h
repertoir
volunt
variou
age
group
influenza
vaccin
laboratori
detect
higher
igm
mutat
load
vaccin
lower
degre
repertoir
divers
vaccin
elderli
individu
anoth
studi
also
detect
smaller
degre
igm
iga
diversif
elderli
individu
receiv
influenza
pneumococc
vaccin
immun
dysregul
expect
deep
sequenc
antibodi
repertoir
patient
autoimmun
primari
immunodefici
provid
import
mechanist
insight
turn
may
guid
develop
appropri
therapi
howev
analys
antibodi
repertoir
patient
immun
dysregul
publish
thu
far
believ
dearth
reflect
recent
develop
igseq
said
studi
report
multipl
sclerosi
cerebrospin
fluid
v
h
gene
repertoir
bias
show
strong
evid
bcell
activ
interest
determin
whether
activ
b
cell
cerebrospin
fluid
reactiv
toward
recent
discov
domin
antigen
multipl
sclerosi
idiopath
cholang
autoimmun
diseas
associ
abnorm
level
serum
igseq
reveal
presenc
larg
clonal
expans
affect
tissu
peripher
blood
clonal
expans
disappear
corticosteroid
treatment
indic
determin
clonal
distinguish
featur
diseas
therefor
constitut
use
tool
differenti
diagnosi
cancer
bcell
leukemia
lymphoma
multipl
myeloma
malign
aris
differ
stage
bcell
develop
fig
bcr
malign
b
cell
constitut
biomark
abund
malign
cell
popul
igseq
vgene
repertoir
peripher
b
cell
bone
marrow
sampl
tumor
even
bloodborn
free
dna
use
diseas
detect
delin
degre
antibodi
evolut
diversif
malign
cell
correl
diseas
progress
relaps
exampl
igseq
v
gene
peripher
blood
facilit
detect
cancer
cell
minim
residu
diseas
follow
treatment
bcell
chronic
lymphocyt
leukemia
cll
common
leukemia
adult
use
igseq
determin
vgene
repertoir
en
mass
detect
presenc
antibodi
encod
leukem
clone
whose
vgene
sequenc
establish
analys
cancer
cell
sampl
initi
treatment
circumv
need
develop
person
pcr
assay
cll
clonotyp
patient
determin
whether
relaps
occur
igseq
also
use
detect
minim
residu
diseas
pediatr
patient
bcell
acut
lymphoblast
leukemia
ball
marker
nonhodgkin
lymphoma
igseq
also
reveal
ball
patient
display
variou
degre
clonotyp
divers
aris
predominantli
v
h
gene
replac
appear
relat
relaps
frequenc
small
degre
bcell
clonal
heterogen
also
observ
cll
degre
vari
base
whether
diseas
origin
unmut
somat
hypermut
b
cell
contrast
malign
clonotyp
multipl
myeloma
diseas
aris
termin
differenti
plasma
cell
bone
marrow
fig
lack
activ
mechan
antibodi
diversif
display
littl
evid
heterogen
note
cll
hematolog
malign
stereotyp
detect
mani
patient
wider
applic
highthroughput
sequenc
detect
malignancystereotyp
clonotyp
may
present
low
frequenc
subject
yet
display
clinic
diseas
may
prove
use
earli
diagnost
tool
lastli
igseq
may
also
appli
understand
gammopathi
condit
result
abnorm
high
level
antibodi
serum
preval
elderli
develop
multipl
myeloma
humor
immun
system
evolv
encod
astonish
divers
antibodi
collect
compris
antibodi
repertoir
provid
potent
arsen
recognit
reagent
anticipatori
receptor
recogn
virtual
organ
macromolecul
biolog
signific
b
lymphocyt
anticipatori
receptor
term
use
emphas
abil
naiv
repertoir
bind
biolog
relev
antigen
ancient
last
common
vertebr
ancestor
million
year
ago
extraordinari
complex
vertebr
adapt
immun
system
liken
titan
brother
epimetheu
hindsight
prometheu
foresight
greek
mytholog
germlin
conserv
antibodi
gene
carri
imprint
ancient
adapt
pathogen
human
expos
evolut
henc
epimethean
scope
hand
immunolog
foresight
repres
repertoir
encod
antigenexperienc
matur
b
cell
within
individu
enabl
adapt
futur
pathogen
challeng
promethean
anticipatori
featur
advent
highthroughput
dna
sequenc
enabl
determin
antibodi
gene
repertoir
unpreced
depth
inconceiv
even
halfadozen
year
ago
begin
deciph
epimethean
promethean
compart
humor
immun
shape
technolog
improv
sequenc
precis
data
analysi
develop
breakneck
pace
reshap
understand
mani
import
aspect
bcell
immunolog
increasingli
affect
clinic
diagnosi
antibodi
drug
discoveri
vaccin
develop
howev
realiz
full
impact
igseq
requir
implement
standard
experiment
annot
data
analysi
well
creation
databas
facilit
deposit
share
import
data
